These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23867070)

  • 41. Antibiotic treatment using amoxicillin-clavulanic acid impairs gut mycobiota development through modification of the bacterial ecosystem.
    Spatz M; Da Costa G; Ventin-Holmberg R; Planchais J; Michaudel C; Wang Y; Danne C; Lapiere A; Michel ML; Kolho KL; Langella P; Sokol H; Richard ML
    Microbiome; 2023 Apr; 11(1):73. PubMed ID: 37032359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diversity of fecal coliforms and their antimicrobial resistance patterns in wastewater treatment model plant.
    Luczkiewicz A; Fudala-Ksiazek S; Jankowska K; Quant B; Olańczuk-Neyman K
    Water Sci Technol; 2010; 61(6):1383-92. PubMed ID: 20351416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry.
    Miñán A; Bosch A; Lasch P; Stämmler M; Serra DO; Degrossi J; Gatti B; Vay C; D'aquino M; Yantorno O; Naumann D
    Analyst; 2009 Jun; 134(6):1138-48. PubMed ID: 19475140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the Ecological Effects of Naturally Antibiotic-Insensitive Bifidobacteria in the Recovery of the Resilience of the Gut Microbiota during and after Antibiotic Treatment.
    Argentini C; Mancabelli L; Alessandri G; Tarracchini C; Barbetti M; Carnevali L; Longhi G; Viappiani A; Anzalone R; Milani C; Sgoifo A; van Sinderen D; Ventura M; Turroni F
    Appl Environ Microbiol; 2022 Jun; 88(12):e0052222. PubMed ID: 35652662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
    González N; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; Cafini F; Coronel P; Prieto J
    J Antimicrob Chemother; 2009 Jun; 63(6):1215-22. PubMed ID: 19307171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fecal colonization of Enterobacteriaceae carrying plasmid-mediated quinolone resistance determinants in Korea.
    Jeong HS; Bae IK; Shin JH; Kim SH; Chang CL; Jeong J; Kim S; Lee CH; Ryoo NH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):507-12. PubMed ID: 21830908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptation of commensal proliferating
    Matamouros S; Hayden HS; Hager KR; Brittnacher MJ; Lachance K; Weiss EJ; Pope CE; Imhaus AF; McNally CP; Borenstein E; Hoffman LR; Miller SI
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1605-1610. PubMed ID: 29378945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010.
    Maraki S; Mantadakis E; Michailidis L; Samonis G
    J Microbiol Immunol Infect; 2013 Jun; 46(3):202-9. PubMed ID: 22795650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discrimination and characterization of environmental strains of Escherichia coli by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS).
    Siegrist TJ; Anderson PD; Huen WH; Kleinheinz GT; McDermott CM; Sandrin TR
    J Microbiol Methods; 2007 Mar; 68(3):554-62. PubMed ID: 17184860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. rpoB gene sequencing highlights the prevalence of an E. miricola cluster over other Elizabethkingia species among UK cystic fibrosis patients.
    Kenna DTD; Fuller A; Martin K; Perry C; Pike R; Burns PJ; Narayan O; Wilkinson S; Hill R; Woodford N; Logan JMJ; Turton JF
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):109-114. PubMed ID: 29174734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic resistance of subgingival species in chronic periodontitis patients.
    Ardila CM; Granada MI; Guzmán IC
    J Periodontal Res; 2010 Aug; 45(4):557-63. PubMed ID: 20546113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Could honey bees signal the spread of antimicrobial resistance in the environment?
    Piva S; Giacometti F; Marti E; Massella E; Cabbri R; Galuppi R; Serraino A
    Lett Appl Microbiol; 2020 May; 70(5):349-355. PubMed ID: 32096241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro activity of BRL 25.000 (amoxycillin plus clavulanic acid) against Enterobacteriaceae betalactamase producers (author's transl)].
    Roy C; Segura C; Tirado M; Fuster C; Foz A
    Med Clin (Barc); 1982 Mar 1-15; 78(5):189-95. PubMed ID: 6978982
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
    Entenza JM; Giddey M; Vouillamoz J; Moreillon P
    Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
    Ruczkowska J; Dolna I
    Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
    [No Abstract]   [Full Text] [Related]  

  • 59. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.
    Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P
    J Cyst Fibros; 2013 May; 12(3):206-15. PubMed ID: 23151540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.
    Iravani A; Richard GA
    Antimicrob Agents Chemother; 1982 Oct; 22(4):672-7. PubMed ID: 7181477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.